Cardea Bio Inc., a biotech company, develops, manufactures, and delivers commercial graphene-based digital biosensor hardware, software, and molecular infrastructure. The company focuses on creating products and applications that enable precision healthcare by improving diagnostic ease, speed, and cost. Its insight biosensors use the conductive and biocompatible nanomaterial graphene to convert biomolecules into digital elements enabling biology to connect directly to digital networks and creating access to biological data. The company was founded in 2013 and is headquartered in San Diego, California.